Lifevantage Corp: management transactions · United States · SEC (Form 4)

About Lifevantage Corp

LifeVantage Corp (NASDAQ: LFVN) is a U.S.-based health and wellness company headquartered in Lehi, Utah, United States. Founded in 2003, the company is best known for its focus on nutrigenomics, a field that examines how nutrition and naturally occurring compounds may influence gene expression and support wellness-related biological processes. For French-speaking investors, LifeVantage fits best as a niche player in preventive health and dietary supplements, with a direct-selling business model that relies heavily on an independent consultant network. The company’s core business centers on health and nutrition products built around the idea of “activation” at the cellular level. Its portfolio includes Protandim-branded supplements, weight-management and metabolic wellness offerings, and broader health products. In 2025 and 2026, LifeVantage highlighted its MindBody GLP-1 System™, a product platform tied to current consumer interest in metabolism and weight management. The company also strengthened its portfolio through the integration of LoveBiome, which expanded LifeVantage into adjacent wellness categories and added another growth lever to the business. From a competitive standpoint, LifeVantage operates in a highly fragmented market where success depends on brand differentiation, scientific credibility, distribution efficiency, and the ability to refresh the product lineup. The company emphasizes science-backed positioning and nutrigenomics-based messaging, but it faces intense competition from supplement companies, functional nutrition brands, and mass-market wellness players. Its international footprint is an important strategic advantage: beyond its U.S. base, LifeVantage has continued expanding the MB System internationally, including into Asia-Pacific, Europe, and other overseas markets. Recent highlights include the international rollout of the MindBody GLP-1 System, the integration of LoveBiome, and continued product and commercial events designed to energize its consultant base. LifeVantage has also communicated fiscal 2026 financial guidance and continues to emphasize product innovation, global business events, and network activation as part of its growth strategy. For investors looking at a small-cap U.S.-listed wellness company on the NASDAQ, LifeVantage offers exposure to a science-oriented direct-selling model with growth potential that depends on product execution, international expansion, and the strength of its consultant-driven sales engine.